LYON, France--(BUSINESS WIRE)--Dec. 2, 2009--
Bruker BioSpin has successfully completed the installation of the
world’s first 1000 MHz ultra-high field NMR AVANCE™ spectrometer at the
Centre de Resonance Magnétique Nucléaire à Très Hauts Champs (CRMN)
in Lyon, France (a joint research unit of CNRS, Ecole Normale Supérieure
de Lyon and Université Lyon 1). The AVANCE
1000 system incorporates a record-breaking 23.5 Tesla
UltraStabilized™ superconducting magnet, and offers unparalleled
research opportunities, both to the CRMN and to other French and
European scientists who will access this unique facility. For the entire
community of thousands of scientists using modern NMR around the world
today, this represents a landmark moment.
The unique ultra-high resolution capabilities and sensitivity of the
AVANCE 1000 will enable breakthroughs in the study of crucial problems
at the frontier of science in areas as diverse as: heterogeneous
catalysis in the context of sustainable development; structure and
dynamics of proteins relevant to complex mechanisms of disease; large
scale population studies of metabolism to understand lifestyle factors,
notably nutrition, in relation to diseases such as cancer.
Professor Lyndon Emsley, Professor of Chemistry at the Ecole Normale
Supérieure de Lyon, commented: “We have been very impressed by the
installation of the 1000 MHz system. The magnet was ramped up to field
quickly and demonstrates excellent homogeneity and drift
characteristics. Due to the great resolution and sensitivity of the 1000
MHz CryoProbe™ and the availability of several solid-state NMR probes
with unmatched specifications, we are already running experiments to
demonstrate the potential of the AVANCE 1000 across a wide range of
applications, and we expect the spectrometer to be open for business on
a routine basis very soon. A great ‘Christmas present’ for European
science, which we are proud to have been able to obtain here in France."
For further information on CRMN, please visit www.ens-lyon.fr/crmn.
For further information on AVANCE 1000, please visit www.bruker-biospin.com/avance1000
.
For information about Bruker BioSpin and Bruker Corporation (NASDAQ:
BRKR), visit www.bruker.com.
Source: Bruker Corporation
Bruker BioSpin
Dr. Thorsten Thiel
Director of Marketing
Communications
Tel: +49 (721) 5161 – 6517
thorsten.thiel@bruker.de
or
CRMN
Professor
Pierre Toulhoat
Director
Tel: +33 1 04 26 23 38 88
Pierre.Toulhoat@univ-lyon1.fr